Vaginal micronised progesterone soft gel capsule for the treatment of threatened miscarriage

Description

In this Product Explainer, Professor of Obstetrics & Gynaecology, William Ledger explains the role of vaginal micronised progesterone, including the indication, safety profile, clinical trial background and guidelines for use for the treatment and management of threatened miscarriage (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Rod Baber

Prof Rod Baber

Menopausal Hormone Therapy - What Dose of Estrogen is Best?

Dr Adam Nelson

Dr Adam Nelson

Cardiovascular Benefits of GLP1s – New Evidence

Dr Kathleen McNamee, Prof Sonia Grover

Dr Kathleen McNamee, Prof Sonia Grover

Oral Contraceptive Pill in Teens

Prof Andrew Sindone

Prof Andrew Sindone

RSV and the Heart

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Emeritus Prof William Ledger

expert

Emeritus Prof William Ledger

Fertility Specialist; City Fertility Sydney, Emeritus Professor of Obstetrics and Gynaecology; School of Medicine, University of New South Wales

Date published: 8 August 2023